This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Oct 1;192(7):774-6.

doi: 10.1164/rccm.201507-1348ED.

The evidence for long-term benefits of restoration of CFTR function continues to grow

Michael P Boyle^{1

2}

Affiliations

Affiliations

¹ 1 Division of Pulmonary and Critical Care Medicine Johns Hopkins University School of Medicine Baltimore, Maryland and.
² 2 Cystic Fibrosis Foundation Bethesda, Maryland.

PMID: 26426780
DOI: 10.1164/rccm.201507-1348ED

Editorial

The evidence for long-term benefits of restoration of CFTR function continues to grow

Michael P Boyle. Am J Respir Crit Care Med. 2015.

. 2015 Oct 1;192(7):774-6.

doi: 10.1164/rccm.201507-1348ED.

Author

Michael P Boyle^{1

2}

Affiliations

¹ 1 Division of Pulmonary and Critical Care Medicine Johns Hopkins University School of Medicine Baltimore, Maryland and.
² 2 Cystic Fibrosis Foundation Bethesda, Maryland.

PMID: 26426780
DOI: 10.1164/rccm.201507-1348ED

No abstract available

PubMed Disclaimer

Comment on

Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data.
Sawicki GS, McKone EF, Pasta DJ, Millar SJ, Wagener JS, Johnson CA, Konstan MW. Sawicki GS, et al. Am J Respir Crit Care Med. 2015 Oct 1;192(7):836-42. doi: 10.1164/rccm.201503-0578OC. Am J Respir Crit Care Med. 2015. PMID: 26132840

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.